IFM Therapeutics

OverviewSuggest Edit

IFM Therapeutics is a biopharmaceutical company. It is focused on the research and development of biological treatments for inflammatory diseases and cancer. The company's mission is to improve the lives of patients by developing small molecule drugs that target the innate immune system.

TypePrivate
Founded2017
HQBoston, US
Websiteifmthera.com

Latest Updates

Employees (est.) (Aug 2020)31
Cybersecurity ratingAMore

Key People/Management at IFM Therapeutics

Martin Seidel

Martin Seidel

Chief Executive Officer
Dennis Dean

Dennis Dean

Chief Development Officer
William R. Roush

William R. Roush

Executive Vice President of Chemistry
Ed Olhava

Ed Olhava

Senior Vice President of Preclinical Development
Michael P. Cooke

Michael P. Cooke

Chief Scientific Officer
Show more

IFM Therapeutics Office Locations

IFM Therapeutics has an office in Boston
Boston, US (HQ)
855 Boylston St 11th floor
Show all (1)

IFM Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

IFM Therapeutics total Funding

$82.5 m

IFM Therapeutics latest funding size

$55.50 m

Time since last funding

8 months ago

IFM Therapeutics investors

IFM Therapeutics's latest funding round in December 2019 was reported to be $55.5 m. In total, IFM Therapeutics has raised $82.5 m
Show all financial metrics

IFM Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

IFM Therapeutics Online and Social Media Presence

Embed Graph

IFM Therapeutics News and Updates

IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer

BOSTON, Jan. 7, 2020 /PRNewswire/ -- IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today announced the appointment of Michael Cooke, Ph.D., as Chief Scientific Officer. In his...

IFM Therapeutics Frequently Asked Questions

  • When was IFM Therapeutics founded?

    IFM Therapeutics was founded in 2017.

  • Who are IFM Therapeutics key executives?

    IFM Therapeutics's key executives are Martin Seidel, Dennis Dean and William R. Roush.

  • How many employees does IFM Therapeutics have?

    IFM Therapeutics has 31 employees.

  • Who are IFM Therapeutics competitors?

    Competitors of IFM Therapeutics include Alligator Bioscience, Phoenix Biotechnology and Akrevia Therapeutics.

  • Where is IFM Therapeutics headquarters?

    IFM Therapeutics headquarters is located at 855 Boylston St 11th floor, Boston.

  • Where are IFM Therapeutics offices?

    IFM Therapeutics has an office in Boston.

  • How many offices does IFM Therapeutics have?

    IFM Therapeutics has 1 office.